Citations (158)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Robin Van Den Borg, Alessandro Leonetti, Marcello Tiseo, Elisa Giovannetti & Godefridus J. Peters. (2019) Novel targeted strategies to overcome resistance in small-cell lung cancer: focus on PARP inhibitors and rovalpituzumab tesirine. Expert Review of Anticancer Therapy 19:6, pages 461-471.
Read now
Read now
Munindra Ruwali, Madhu Singh, Mohan C. Pant & Devendra Parmar. (2011) Polymorphism in glutathione S-transferases: Susceptibility and treatment outcome for head and neck cancer. Xenobiotica 41:12, pages 1122-1130.
Read now
Read now
Ki Han Kim, Hyuk-Chan Kwon, Sung Yong Oh, Sung Hyun Kim, Suee Lee, Kyung A Kwon, Jin Seok Jang, Min Chan Kim, Su-Jin Kim & Hyo-Jin Kim. (2011) Clinicopathologic significance of ERCC1, thymidylate synthase and glutathione S-transferase P1 expression for advanced gastric cancer patients receiving adjuvant 5-FU and cisplatin chemotherapy. Biomarkers 16:1, pages 74-82.
Read now
Read now
Katalin Jemnitz, Krisztina Heredi-Szabo, Judit Janossy, Eniko Ioja, Laszlo Vereczkey & Peter Krajcsi. (2010) ABCC2/Abcc2: a multispecific transporter with dominant excretory functions. Drug Metabolism Reviews 42:3, pages 402-436.
Read now
Read now
Michelle AT Hildebrandt, Jian Gu & Xifeng Wu. (2009) Pharmacogenomics of platinum-based chemotherapy in NSCLC. Expert Opinion on Drug Metabolism & Toxicology 5:7, pages 745-755.
Read now
Read now
Ugur Gonlugur, Hatice Pinarbasi, Tanseli Efeoglu Gonlugur & Yavuz Silig. (2006) The Association Between Polymorphisms in Glutathione S-Transferase (GSTM1 and GSTT1) and Lung Cancer Outcome. Cancer Investigation 24:5, pages 497-501.
Read now
Read now
Kenneth D Tew. (2005) TLK-286: a novel glutathione S-transferase-activated prodrug. Expert Opinion on Investigational Drugs 14:8, pages 1047-1054.
Read now
Read now
Articles from other publishers (151)
Min Zhong, Peiqin Liang, Zhenzhen Feng, Xin Yang, Guang Li, Rui Sun, Lijuan He, Jinxiu Tan, Yangpengcheng Xiao, Zhiqiang Yu, Muhua Yi & Xuefeng Wang. (2023) A nanocomposite competent to overcome cascade drug resistance in ovarian cancer via mitochondria dysfunction and NO gas synergistic therapy. Asian Journal of Pharmaceutical Sciences 18:6, pages 100872.
Crossref
Crossref
Shunzhe Zheng, Guanting Li, Jianbin Shi, Xinying Liu, Meng Li, Zhonggui He, Chutong Tian & Ken-ichiro Kamei. (2023) Emerging platinum(IV) prodrug nanotherapeutics: A new epoch for platinum-based cancer therapy. Journal of Controlled Release 361, pages 819-846.
Crossref
Crossref
Meifang Wang, Ping'an Ma & Jun Lin. (2023) Nanoplatform-based cellular reactive oxygen species regulation for enhanced oncotherapy and tumor resistance alleviation. Chinese Chemical Letters 34:9, pages 108300.
Crossref
Crossref
Aleksandra Zoń & Ilona Bednarek. (2023) Cisplatin in Ovarian Cancer Treatment—Known Limitations in Therapy Force New Solutions. International Journal of Molecular Sciences 24:8, pages 7585.
Crossref
Crossref
Huanhuan Sha, Renrui Zou, Ya Lu, Yujie Gan, Rong Ma, Jifeng Feng & Dan Chen. (2022) NBDHEX re‐sensitizes adriamycin‐resistant breast cancer by inhibiting glutathione S‐transferase pi. Cancer Medicine 12:5, pages 5833-5845.
Crossref
Crossref
Yuanyuan Yang, Ziyi Mai, Yanxin Zhang, Zhiyu Yu, Wenjing Li, Yuxuan Zhang, Fangzhou Li, Peter Timashev, Ping Luan, Dixian Luo, Xing-Jie Liang & Zhiqiang Yu. (2023) A Cascade Targeted and Mitochondrion-Dysfunctional Nanomedicine Capable of Overcoming Drug Resistance in Hepatocellular Carcinoma. ACS Nano 17:2, pages 1275-1286.
Crossref
Crossref
Maria Konoshenko, Yuriy Lansukhay, Sergey Krasilnikov & Pavel Laktionov. (2022) MicroRNAs as Predictors of Lung-Cancer Resistance and Sensitivity to Cisplatin. International Journal of Molecular Sciences 23:14, pages 7594.
Crossref
Crossref
Chiara Colarusso, Michela Terlizzi, Aldo Pinto & Rosalinda Sorrentino. 2022.
Adolfo I. B. Romo, Marta P. Carepo, Pedro Levín, Otaciro R. Nascimento, Daniel E. Díaz, Joaquín Rodríguez-López, Ignácio E. León, Lucas F. Bezerra, Luis Lemus & Izaura C. N. Diógenes. (2021) Synergy of DNA intercalation and catalytic activity of a copper complex towards improved polymerase inhibition and cancer cell cytotoxicity. Dalton Transactions 50:34, pages 11931-11940.
Crossref
Crossref
Yi Chen. (2021) Recent progress in natural product-based inhibitor screening with enzymatic fluorescent probes. Analytical Methods 13:15, pages 1778-1787.
Crossref
Crossref
Yan Qin, Caiyun Peng, Wei Yang, Jialong Fan, Wen-Bing Sheng, Pan Yi, Yixing Qiu, Huanghe Yu, Sai Jiang, Wei Wang & Bin Liu. (2021) A bi-functional fluorescent probe for visualized and rapid natural drug screening via GSTs activity monitoring. Sensors and Actuators B: Chemical 328, pages 129047.
Crossref
Crossref
Fang Gao, Xue Yang, Xinping Luo, Xuling Xue, Chenggen Qian & Minjie Sun. (2020) Photoactivated Nanosheets Accelerate Nucleus Access of Cisplatin for Drug‐Resistant Cancer Therapy. Advanced Functional Materials 30:49, pages 2001546.
Crossref
Crossref
Yuanyuan Yang, Yingjie Yu, Hao Chen, Xiangxi Meng, Wen Ma, Meng Yu, Ziyuan Li, Changhui Li, Haile Liu, Xiaodong Zhang, Haihua Xiao & Zhiqiang Yu. (2020)
Illuminating Platinum Transportation while Maximizing Therapeutic Efficacy by Gold Nanoclusters
via
Simultaneous Near-Infrared-I/II Imaging and Glutathione Scavenging
. ACS Nano 14:10, pages 13536-13547.
Crossref
Crossref
Claudia Pellacani & Georgios Eleftheriou. (2020) Neurotoxicity of antineoplastic drugs: Mechanisms, susceptibility, and neuroprotective strategies. Advances in Medical Sciences 65:2, pages 265-285.
Crossref
Crossref
Nefertiti Muhammad, Hyun Min Lee & Jiyeon Kim. (2020) Oncology Therapeutics Targeting the Metabolism of Amino Acids. Cells 9:8, pages 1904.
Crossref
Crossref
Jose J. G. Marin, Laura Perez-Silva, Rocio I. R. Macias, Maitane Asensio, Ana Peleteiro-Vigil, Anabel Sanchez-Martin, Candela Cives-Losada, Paula Sanchon-Sanchez, Beatriz Sanchez De Blas, Elisa Herraez, Oscar Briz & Elisa Lozano. (2020) Molecular Bases of Mechanisms Accounting for Drug Resistance in Gastric Adenocarcinoma. Cancers 12:8, pages 2116.
Crossref
Crossref
Da Huo, Xiqun Jiang & Yong Hu. (2019) Recent Advances in Nanostrategies Capable of Overcoming Biological Barriers for Tumor Management. Advanced Materials 32:27.
Crossref
Crossref
Sophie Möltgen, Eleonora Piumatti, Giuseppe Massafra, Sabine Metzger, Ulrich Jaehde & Ganna Kalayda. (2020) Cisplatin Protein Binding Partners and Their Relevance for Platinum Drug Sensitivity. Cells 9:6, pages 1322.
Crossref
Crossref
Arzu KAYA KOÇDOĞAN, Serpil OĞUZTÜZÜN, Gülçin GÜLER ŞİMŞEK & Mustafa TÜRK. (2020) MCF-7 İnsan Meme Kanseri Hücre Soyunda Doksorubisin Öncesi ve Sonrası GST İzozimlerinin, İlaç Dirençlilik Proteinlerinin ve Apoptotik Etkisinin AraştırılmasıInvestigation of GST Isoenzymes, Multi-Drug Resistance Proteins and Apoptotic Effect in MCF-7 Human Breast Cancer Cell Line Before and After Doxorubicin Treatment. İstanbul Gelişim Üniversitesi Sağlık Bilimleri Dergisi:10, pages 1-18.
Crossref
Crossref
Golara Golbaghi & Annie Castonguay. (2020) Rationally Designed Ruthenium Complexes for Breast Cancer Therapy. Molecules 25:2, pages 265.
Crossref
Crossref
João Marcos Galúcio, Elton Figueira Monteiro, Deivid Almeida de Jesus, Clauber Henrique Costa, Raissa Caroline Siqueira, Gabriela Bianchi dos Santos, Jerônimo Lameira & Kauê Santana da Costa. (2019) In silico identification of natural products with anticancer activity using a chemo-structural database of Brazilian biodiversity. Computational Biology and Chemistry 83, pages 107102.
Crossref
Crossref
Anastasia De Luca, Lorien J. ParkerWee Han AngCarlo RodolfoValentina GabbariniNancy C. HancockFrancesca PaloneAnna P. MazzettiLaure Menin, Craig J. Morton, Michael W. Parker, Mario Lo BelloPaul J. Dyson. (2019) A structure-based mechanism of cisplatin resistance mediated by glutathione transferase P1-1. Proceedings of the National Academy of Sciences 116:28, pages 13943-13951.
Crossref
Crossref
Xin Dai, Xueying Zhou, Chunyan Liao, Yongchao Yao, Yunlong Yu & Shiyong Zhang. (2019)
A nanodrug to combat cisplatin-resistance by protecting cisplatin with
p
-sulfonatocalix[4]arene and regulating glutathione
S
-transferases with loaded 5-fluorouracil
. Chemical Communications 55:50, pages 7199-7202.
Crossref
Crossref
Jie Zhang, Zhi-wei Ye, Danyelle M. Townsend, Chanita Hughes-Halbert & Kenneth D. Tew. 2019.
343
383
.
Surya Kant Tripathi, Kamal Pandey, Munmun Panda & Bijesh K. Biswal. 2019. AGO-Driven Non-Coding RNAs. AGO-Driven Non-Coding RNAs
293
318
.
Marzieh Ghanbarian, Ali Afgar, Reza Yadegarazari, Rezvan Najafi & Ladan Teimoori-Toolabi. (2018) Through oxaliplatin resistance induction in colorectal cancer cells, increasing ABCB1 level accompanies decreasing level of miR-302c-5p, miR-3664-5p and miR-129-5p. Biomedicine & Pharmacotherapy 108, pages 1070-1080.
Crossref
Crossref
Xiang Ling, Xing Chen, Imogen A. Riddell, Wei Tao, Junqing Wang, Geoffrey Hollett, Stephen J. Lippard, Omid C. Farokhzad, Jinjun Shi & Jun Wu. (2018) Glutathione-Scavenging Poly(disulfide amide) Nanoparticles for the Effective Delivery of Pt(IV) Prodrugs and Reversal of Cisplatin Resistance. Nano Letters 18:7, pages 4618-4625.
Crossref
Crossref
Tomoko Yoshihama, Koya Fukunaga, Akira Hirasawa, Hiroyuki Nomura, Tomoko Akahane, Fumio Kataoka, Wataru Yamagami, Daisuke Aoki & Taisei Mushiroda. (2018)
GSTP1
rs1695 is associated with both hematological toxicity and prognosis of ovarian cancer treated with paclitaxel plus carboplatin combination chemotherapy: a comprehensive analysis using targeted resequencing of 100 pharmacogenes
. Oncotarget 9:51, pages 29789-29800.
Crossref
Crossref
Danijela Petrovic, Mariana Seke, Milica Labudovic Borovic, Danica Jovic, Ivana Borisev, Branislava Srdjenovic, Zlatko Rakocevic, Vladimir Pavlovic & Aleksandar Djordjevic. (2018) Hepatoprotective effect of fullerenol/doxorubicin nanocomposite in acute treatment of healthy rats. Experimental and Molecular Pathology 104:3, pages 199-211.
Crossref
Crossref
Raffaele Palmirotta, Claudia Carella, Erica Silvestris, Mauro Cives, Stefania Luigia Stucci, Marco Tucci, Domenica Lovero & Franco Silvestris. (2018) SNPs in predicting clinical efficacy and toxicity of chemotherapy: walking through the quicksand. Oncotarget 9:38, pages 25355-25382.
Crossref
Crossref
Shuyi Li, Chan Li, Shubin Jin, Juan Liu, Xiangdong Xue, Ahmed Shaker Eltahan, Jiadong Sun, Jingjie Tan, Jinchen Dong & Xing-Jie Liang. (2017) Overcoming resistance to cisplatin by inhibition of glutathione S-transferases (GSTs) with ethacraplatin micelles in vitro and in vivo. Biomaterials 144, pages 119-129.
Crossref
Crossref
R. Sirota, D. Gibson & R. Kohen. (2017) The timing of caffeic acid treatment with cisplatin determines sensitization or resistance of ovarian carcinoma cell lines. Redox Biology 11, pages 170-175.
Crossref
Crossref
Nabil El Brahmi, Saïd El Kazzouli, Serge Mignani, Régis Laurent, Sonia Ladeira, Anne-Marie Caminade, Mosto Bousmina & Jean-Pierre Majoral. (2017) Symmetrical and unsymmetrical incorporation of active biological monomers on the surface of phosphorus dendrimers. Tetrahedron 73:10, pages 1331-1341.
Crossref
Crossref
Daisy L. Wong, Angel Zhang, Abayomi S. Faponle, Sam P. de Visser & Martin J. Stillman. (2017) Glutathione binding to dirhodium tetraacetate: a spectroscopic, mass spectral and computational study of an anti-tumour compound. Metallomics 9:5, pages 501-516.
Crossref
Crossref
Roman Mezencev, Lilya V. Matyunina, Neda Jabbari & John F. McDonald. (2016) Snail-induced epithelial-to-mesenchymal transition of MCF-7 breast cancer cells: systems analysis of molecular changes and their effect on radiation and drug sensitivity. BMC Cancer 16:1.
Crossref
Crossref
Kaitlin A. Doucette, Kelly N. Hassell & Debbie C. Crans. (2016) Selective speciation improves efficacy and lowers toxicity of platinum anticancer and vanadium antidiabetic drugs. Journal of Inorganic Biochemistry 165, pages 56-70.
Crossref
Crossref
Serge Mignani, Nabil El Brahmi, Saïd El Kazzouli, Laure Eloy, Delphine Courilleau, Joachim Caron, Mosto M. Bousmina, Anne-Marie Caminade, Thierry Cresteil & Jean-Pierre Majoral. (2016) A novel class of ethacrynic acid derivatives as promising drug-like potent generation of anticancer agents with established mechanism of action. European Journal of Medicinal Chemistry 122, pages 656-673.
Crossref
Crossref
Alfeu Zanotto-Filho, Ravi Dashnamoorthy, Eva Loranc, Luis H. T. de Souza, José C. F. Moreira, Uthra Suresh, Yidong Chen & Alexander J. R. Bishop. (2016) Combined Gene Expression and RNAi Screening to Identify Alkylation Damage Survival Pathways from Fly to Human. PLOS ONE 11:4, pages e0153970.
Crossref
Crossref
Mashitoh Abd Rahman, Faiqah Ramli, Hamed Karimian, Firouzeh Dehghan, Noraziah Nordin, Hapipah Mohd Ali, Syam Mohan & Najihah Mohd Hashim. (2016) Artonin E Induces Apoptosis via Mitochondrial Dysregulation in SKOV-3 Ovarian Cancer Cells. PLOS ONE 11:3, pages e0151466.
Crossref
Crossref
Rakesh K. Pathak & Shanta Dhar. (2016)
Unique Use of Alkylation for Chemo‐Redox Activity by a Pt
IV
Prodrug
. Chemistry – A European Journal 22:9, pages 3029-3036.
Crossref
Crossref
Ewa Usarek, Wojciech Graboń, Beata Kaźmierczak & Anna Barańczyk-Kuźma. (2016) Targeting the expression of glutathione- and sulfate-dependent detoxification enzymes in HepG2 cells by oxygen in minimal and amino acid enriched medium. Experimental and Molecular Pathology 100:1, pages 82-86.
Crossref
Crossref
Shengchao Lin, Kecheng Lei, Wenpei Du, Liyan Yang, Haiyang Shi, Yuwei Gao, Peihao Yin, Xin Liang & Jianwen Liu. (2016) Enhancement of oxaliplatin sensitivity in human colorectal cancer by hypericin mediated photodynamic therapy via ROS-related mechanism. The International Journal of Biochemistry & Cell Biology 71, pages 24-34.
Crossref
Crossref
Rujiao Liu, Xiaoying Zhao, Xin Liu, Zhiyu Chen, Lixin Qiu, Ruixuan Geng, Weijian Guo, Guang He, Jiliang Yin, Jin Li & Xiaodong Zhu. (2015) Influences of ERCC1, ERCC2, XRCC1, GSTP1, GSTT1, and MTHFR polymorphisms on clinical outcomes in gastric cancer patients treated with EOF chemotherapy. Tumor Biology 37:2, pages 1753-1762.
Crossref
Crossref
Uttara Basu, Bhabatosh Banik, Ru Wen, Rakesh K. Pathak & Shanta Dhar. (2016) The Platin-X series: activation, targeting, and delivery. Dalton Transactions 45:33, pages 12992-13004.
Crossref
Crossref
Yasuo Iwamoto, Tetsuya Mitsudomi, Kazuko Sakai, Takeharu Yamanaka, Hiroshige Yoshioka, Makoto Takahama, Masahiro Yoshimura, Ichiro Yoshino, Masayuki Takeda, Shunichi Sugawara, Tomoya Kawaguchi, Toshiaki Takahashi, Mitsunori Ohta, Yukito Ichinose, Shinji Atagi, Morihito Okada, Hideo Saka, Kazuhiko Nakagawa, Yoichi Nakanishi & Kazuto Nishio. (2015) Randomized Phase II Study of Adjuvant Chemotherapy with Long-term S-1 versus Cisplatin+S-1 in Completely Resected Stage II–IIIA Non–Small Cell Lung Cancer. Clinical Cancer Research 21:23, pages 5245-5252.
Crossref
Crossref
Mohammad Abbas, Vandana Singh Kushwaha, Kirti Srivastava & Monisha Banerjee. (2015) Glutathione S-Transferase Gene Polymorphisms and Treatment Outcome in Cervical Cancer Patients under Concomitant Chemoradiation. PLOS ONE 10:11, pages e0142501.
Crossref
Crossref
Eva Martinez-Balibrea, Anna Martínez-Cardús, Alba Ginés, Vicenç Ruiz de Porras, Catia Moutinho, Laura Layos, José Luis Manzano, Cristina Bugés, Sara Bystrup, Manel Esteller & Albert Abad. (2015) Tumor-Related Molecular Mechanisms of Oxaliplatin Resistance. Molecular Cancer Therapeutics 14:8, pages 1767-1776.
Crossref
Crossref
A Brockmann, A Bluwstein, A Kögel, S May, A Marx, M P Tschan & T Brunner. (2015) Thiazolides promote apoptosis in colorectal tumor cells via MAP kinase-induced Bim and Puma activation. Cell Death & Disease 6:6, pages e1778-e1778.
Crossref
Crossref
M. López-Gómez, J. Moreno-Rubio, I. Suárez-García, P. Cejas, R. Madero, E. Casado, A. M. Jiménez, M. Sereno, C. Gómez-Raposo, F. Zambrana, M. Merino, D. Fernández-Luengas & J. Feliu. (2014) Gene expression differences in primary colorectal tumors and matched liver metastases: chemotherapy related or tumoral heterogeneity?. Clinical and Translational Oncology 17:4, pages 322-329.
Crossref
Crossref
Nabil El Brahmi, Serge M. Mignani, Joachim Caron, Saïd El Kazzouli, Mosto M. Bousmina, Anne-Marie Caminade, Thierry Cresteil & Jean-Pierre Majoral. (2015) Investigations on dendrimer space reveal solid and liquid tumor growth-inhibition by original phosphorus-based dendrimers and the corresponding monomers and dendrons with ethacrynic acid motifs. Nanoscale 7:9, pages 3915-3922.
Crossref
Crossref
Anette Brockmann, Tobias Strittmatter, Sarah May, Kerstin Stemmer, Andreas Marx & Thomas Brunner. (2014) Structure–Function Relationship of Thiazolide-Induced Apoptosis in Colorectal Tumor Cells. ACS Chemical Biology 9:7, pages 1520-1527.
Crossref
Crossref
Devarajan Thangadurai & Jeyabalan SangeethaRownock Afruza, Fumiaki Suzuki & A Nabi. 2014. Biotechnology and Bioinformatics. Biotechnology and Bioinformatics
35
71
.
Alice V. Klein & Trevor W. Hambley. 2014. Ligand Design in Medicinal Inorganic Chemistry. Ligand Design in Medicinal Inorganic Chemistry
9
45
.
HIRONORI KITADE, TAKEO SHIMASAKI, SAYA IGARASHI, HIROSHI SAKUMA, MITSUE MORI, NAOHISA TOMOSUGI & MASUO NAKAI. (2014) Long-term administration and efficacy of oxaliplatin with no neurotoxicity in a patient with rectal cancer: Association between neurotoxicity and the GSTP1 polymorphism. Oncology Letters 7:5, pages 1499-1502.
Crossref
Crossref
Xiaodi Ding, Xiujuan Qu, Yibo Fan, Xiaofang Che, Jinglei Qu, Ling Xu, Jing Liu & Yunpeng Liu. (2014) Trastuzumab and oxaliplatin exhibit a synergistic antitumor effect in HER2-postive gastric cancer cells. Anti-Cancer Drugs 25:3, pages 315-322.
Crossref
Crossref
Beatrice Mohelnikova-Duchonova. (2014) FOLFOX/FOLFIRI pharmacogenetics: The call for a personalized approach in colorectal cancer therapy. World Journal of Gastroenterology 20:30, pages 10316.
Crossref
Crossref
Qiang Yang, Haihua Xiao, Jing Cai, Zhigang Xie, Zehua Wang & Xiabin Jing. (2014) Nanoparticle mediated delivery of a GST inhibitor ethacrynic acid for sensitizing platinum based chemotherapy. RSC Adv. 4:105, pages 61124-61132.
Crossref
Crossref
Xianghui Zeng, Ralf Morgenstern & Andreas M. Nyström. (2014) Nanoparticle-directed sub-cellular localization of doxorubicin and the sensitization breast cancer cells by circumventing GST-Mediated drug resistance. Biomaterials 35:4, pages 1227-1239.
Crossref
Crossref
Jie Zhang, Christina Grek, Zhi-Wei Ye, Yefim Manevich, Kenneth D. Tew & Danyelle M. Townsend. 2014. Redox and Cancer Part A. Redox and Cancer Part A
143
175
.
Deepika Shukla, Alka Dinesh Kale, Seema Hallikerimath, Venkatakanthaiah Yerramalla, Vivekanandhan Subbiah & Shashwat Mishra. (2013) Association between GSTM1 and CYP1A1 polymorphisms and survival in oral cancer patients. Biomedical Papers 157:4, pages 304-310.
Crossref
Crossref
Minhui Lin, Jianda Hu, Tingbo Liu, Jing Li, Buyuan Chen & Xinji Chen. (2013) Knockdown of nucleophosmin by RNA interference reverses multidrug resistance in resistant leukemic HL-60 cells. Immunobiology 218:9, pages 1147-1154.
Crossref
Crossref
Christina Kline & Wafik El-Deiry. (2013) Personalizing Colon Cancer Therapeutics: Targeting Old and New Mechanisms of Action. Pharmaceuticals 6:8, pages 988-1038.
Crossref
Crossref
Zhi Peng, Qianqian Wang, Jing Gao, Zhaoning Ji, Jiajia Yuan, Ye Tian & Lin Shen. (2013) Association between GSTP1 Ile105Val polymorphism and oxaliplatin-induced neuropathy: a systematic review and meta-analysis. Cancer Chemotherapy and Pharmacology 72:2, pages 305-314.
Crossref
Crossref
Tarek K. Motawi, Hanan M. Abd-Elgawad & Nancy N. Shahin. (2013) Effect of protein malnutrition on the metabolism and toxicity of cisplatin, 5-fluorouracil and mitomycin C in rat stomach. Food and Chemical Toxicology 56, pages 467-482.
Crossref
Crossref
Y. Manevich, S. Hutchens, K.D. Tew & D.M. Townsend. (2013) Allelic variants of glutathione S-transferase P1-1 differentially mediate the peroxidase function of peroxiredoxin VI and alter membrane lipid peroxidation. Free Radical Biology and Medicine 54, pages 62-70.
Crossref
Crossref
Ilaria Zanellato, Ilaria Bonarrigo, Elisabetta Gabano, Mauro Ravera, Nicola Margiotta, Pier-Giacomo Betta & Domenico Osella. (2012) Metallo-drugs in the treatment of malignant pleural mesothelioma. Inorganica Chimica Acta 393, pages 64-74.
Crossref
Crossref
E. V. Kalinina, T. T. Berozov, A. A. Shtil, N. N. Chernov, V. A. Glasunova, M. D. Novichkova & N. K. Nurmuradov. (2012) Expression of Genes of Glutathione Transferase Isoforms GSTP1-1, GSTA4-4, and GSTK1-1 in Tumor Cells during the Formation of Drug Resistance to Cisplatin. Bulletin of Experimental Biology and Medicine 154:1, pages 64-67.
Crossref
Crossref
D Sidler, A Brockmann, J Mueller, U Nachbur, N Corazza, P Renzulli, A Hemphill & T Brunner. (2011) Thiazolide-induced apoptosis in colorectal cancer cells is mediated via the Jun kinase–Bim axis and reveals glutathione-S-transferase P1 as Achilles’ heel. Oncogene 31:37, pages 4095-4106.
Crossref
Crossref
J. Brackett, K. R. Krull, M. E. Scheurer, W. Liu, D. K. Srivastava, M. Stovall, T. E. Merchant, R. J. Packer, L. L. Robison & M. F. Okcu. (2012) Antioxidant enzyme polymorphisms and neuropsychological outcomes in medulloblastoma survivors: a report from the Childhood Cancer Survivor Study. Neuro-Oncology 14:8, pages 1018-1025.
Crossref
Crossref
Yuri Kusano, Shunsuke Horie, Nozomi Morishita, Takahiro Shibata & Koji Uchida. (2012) Constitutive expression of an antioxidant enzyme, glutathione S-transferase P1, during differentiation of human intestinal Caco-2 cells. Free Radical Biology and Medicine 53:2, pages 347-356.
Crossref
Crossref
Angela Casini & Jan Reedijk. (2012) Interactions of anticancer Pt compounds with proteins: an overlooked topic in medicinal inorganic chemistry?. Chemical Science 3:11, pages 3135.
Crossref
Crossref
Ilaria Zanellato, Ilaria Bonarrigo, Manuele Sardi, Manuela Alessio, Elisabetta Gabano, Mauro Ravera & Domenico Osella. (2011) Evaluation of Platinum-Ethacrynic Acid Conjugates in the Treatment of Mesothelioma. ChemMedChem 6:12, pages 2287-2293.
Crossref
Crossref
Lin Ruan, Xin-Hui Li, Xun-Xun Wan, Hong Yi, Cui Li, Mao-Yu Li, Peng-Fei Zhang, Gu-Qing Zeng, Jia-Quan Qu, Qiu-Yan He, Jian-Huang Li, Yu Chen, Zhu-Chu Chen & Zhi-Qiang Xiao. (2011) Analysis of EGFR signaling pathway in nasopharyngeal carcinoma cells by quantitative phosphoproteomics. Proteome Science 9:1.
Crossref
Crossref
In Sil Choi, Hye Seung Lee, Keun-Wook Lee, Haeryoung Kim, Ki Hwan Kim, Yu Jung Kim, Jee Hyun Kim, Woo Ho Kim & Jong Seok Lee. (2010) Biomarker analysis in patients with advanced gastric cancer treated with S-1 plus cisplatin chemotherapy: orotate phosphoribosyltransferase expression is associated with treatment outcomes. Medical Oncology 28:4, pages 991-998.
Crossref
Crossref
Katarina Johansson, Mika Ito, Carolien M. S. Schophuizen, Sherin Mathew Thengumtharayil, Vanina D. Heuser, Jie Zhang, Miyuki Shimoji, Marie Vahter, Wee Han Ang, Paul J. Dyson, Aya Shibata, Satoshi Shuto, Yoshihiro, Ito, Hiroshi Abe & Ralf Morgenstern. (2011) Characterization of New Potential Anticancer Drugs Designed To Overcome Glutathione Transferase Mediated Resistance. Molecular Pharmaceutics 8:5, pages 1698-1708.
Crossref
Crossref
Debashree Mukherjea & Leonard P Rybak. (2011) Pharmacogenomics of cisplatin-induced ototoxicity. Pharmacogenomics 12:7, pages 1039-1050.
Crossref
Crossref
Kenneth D. Tew, Yefim Manevich, Christina Grek, Ying Xiong, Joachim Uys & Danyelle M. Townsend. (2011) The role of glutathione S-transferase P in signaling pathways and S-glutathionylation in cancer. Free Radical Biology and Medicine 51:2, pages 299-313.
Crossref
Crossref
Soumya Chatterjee, Ilaria Biondi, Paul J. Dyson & Arindam Bhattacharyya. (2011) A bifunctional organometallic ruthenium drug with multiple modes of inducing apoptosis. JBIC Journal of Biological Inorganic Chemistry 16:5, pages 715-724.
Crossref
Crossref
Junshik Hong, Sae-Won Han, Hye Seon Ham, Tae-Yong Kim, In Sil Choi, Byung-Su Kim, Do-Youn Oh, Seock-Ah Im, Gyeong Hoon Kang, Yung-Jue Bang & Tae-You Kim. (2010) Phase II study of biweekly S-1 and oxaliplatin combination chemotherapy in metastatic colorectal cancer and pharmacogenetic analysis. Cancer Chemotherapy and Pharmacology 67:6, pages 1323-1331.
Crossref
Crossref
Ming-Yii Huang, Meng-Lin Huang, Ming-Jenn Chen, Chien-Yu Lu, Chin-Fan Chen, Pei-Chien Tsai, Shih-Chang Chuang, Ming-Feng Hou, Shiu-Ru Lin & Jaw-Yuan Wang. (2011) Multiple genetic polymorphisms in the prediction of clinical outcome of metastatic colorectal cancer patients treated with first-line FOLFOX-4 chemotherapy. Pharmacogenetics and Genomics 21:1, pages 18-25.
Crossref
Crossref
Ajanta Chakraborty, Pramod Kumar, Kaushik Ghosh & Partha Roy. (2010) Evaluation of a Schiff base copper complex compound as potent anticancer molecule with multiple targets of action. European Journal of Pharmacology 647:1-3, pages 1-12.
Crossref
Crossref
William A. Paradise, Benjamin J. Vesper, Ajay Goel, Joshua D. Waltonen, Kenneth W. Altman, G. Kenneth HainesIIIIII & James A. Radosevich. (2010) Nitric Oxide: Perspectives and Emerging Studies of a Well Known Cytotoxin. International Journal of Molecular Sciences 11:7, pages 2715-2745.
Crossref
Crossref
Xinmei Yang, Guyue Liu, Hongcai Li, Yun Zhang, Dandan Song, Chunmin Li, Rui Wang, Bo Liu, Wen Liang, Yongkui Jing & Guisen Zhao. (2010)
Novel Oxadiazole Analogues Derived from Ethacrynic Acid: Design, Synthesis, and Structure−Activity Relationships in Inhibiting the Activity of Glutathione
S
-Transferase P1-1 and Cancer Cell Proliferation
. Journal of Medicinal Chemistry 53:3, pages 1015-1022.
Crossref
Crossref
Yen-Chung Chen, Cheng-Hwai Tzeng, Po-Min Chen, Jen-Kou Lin, Tzu-Chen Lin, Wei-Shone Chen, Jeng-Kae Jiang, Huann-Sheng Wang & Wei-Shu Wang. (2010)
Influence of
GSTP1
I105V polymorphism on cumulative neuropathy and outcome of FOLFOX-4 treatment in Asian patients with colorectal carcinoma
. Cancer Science 101:2, pages 530-535.
Crossref
Crossref
Ning Sun, Xinchen Sun, Baoan Chen, Hongyan Cheng, Jifeng Feng, Lu Cheng & Zuhong Lu. (2009) MRP2 and GSTP1 polymorphisms and chemotherapy response in advanced non-small cell lung cancer. Cancer Chemotherapy and Pharmacology 65:3, pages 437-446.
Crossref
Crossref
Qing-Fang LiRu-Yong YaoKe-wei LiuHong-Ying LvTao JiangJun Liang. (2010) Genetic Polymorphism of GSTP1: Prediction of Clinical Outcome to Oxaliplatin/5-FU-based Chemotherapy in Advanced Gastric Cancer. Journal of Korean Medical Science 25:6, pages 846.
Crossref
Crossref
Mario Scartozzi, Alessandro Bittoni, Mirco Pistelli, Eva Galizia, Rossana Berardi, Riccardo Giampieri, Luca Faloppi & Stefano Cascinu. (2009) Toward molecularly selected chemotherapy for advanced gastric cancer: State of the art and future perspectives. Cancer Treatment Reviews 35:5, pages 451-462.
Crossref
Crossref
Danyelle M. Townsend, Haim Tapiero & Kenneth D. Tew. 2009. Glutathione and Sulfur Amino Acids in Human Health and Disease. Glutathione and Sulfur Amino Acids in Human Health and Disease
317
342
.
Nadia Barahmani, Sarah Carpentieri, Xio-Nan Li, Tao Wang, Yumei Cao, Laura Howe, Lindsay Kilburn, Murali Chintagumpala, Ching Lau & M. Fatih Okcu. (2009) Glutathione S-transferase M1 and T1 polymorphisms may predict adverse effects after therapy in children with medulloblastoma. Neuro-Oncology 11:3, pages 292-300.
Crossref
Crossref
Tatsunori Okamura, Simendra Singh, John Buolamwini, Timothy Haystead, Henry Friedman, Darell Bigner & Francis Ali-Osman. (2009) Tyrosine Phosphorylation of the Human Glutathione S-Transferase P1 by Epidermal Growth Factor Receptor. Journal of Biological Chemistry 284:25, pages 16979-16989.
Crossref
Crossref
Masahiko Nishiyama & Hidetaka Eguchi. (2009) Pharmacokinetics and pharmacogenomics in gastric cancer chemotherapy. Advanced Drug Delivery Reviews 61:5, pages 402-407.
Crossref
Crossref
Sung-Hyun Kim, Hyuk-Chan Kwon, Sung Yong Oh, Dong Mee Lee, Suee Lee, Jong-Hoon Lee, Mee-Sook Roh, Dae-Cheol Kim, Ki-Jae Park, Hong-Jo Choi & Hyo-Jin Kim. (2009) Prognostic Value of ERCC1, Thymidylate Synthase, and Glutathione S-Transferase π for 5-FU/Oxaliplatin Chemotherapy in Advanced Colorectal Cancer. American Journal of Clinical Oncology 32:1, pages 38-43.
Crossref
Crossref
M. L. Cote, W. Chen, D. W. Smith, S. Benhamou, C. Bouchardy, D. Butkiewicz, K. M. Fong, M. Gene, A. Hirvonen, C. Kiyohara, J. E. Larsen, P. Lin, O. Raaschou-Nielsen, A. C. Povey, E. Reszka, A. Risch, J. Schneider, A. G. Schwartz, M. Sorensen, J. To-Figueras, S. Tokudome, Y. Pu, P. Yang, A. S. Wenzlaff, H. Wikman & E. Taioli. (2009) Meta- and Pooled Analysis of GSTP1 Polymorphism and Lung Cancer: A HuGE-GSEC Review. American Journal of Epidemiology 169:7, pages 802-814.
Crossref
Crossref
Ming-Yii Huang, Wei-Yu Fang, Su-Chen Lee, Tian-Lu Cheng, Jaw-Yuan Wang & Shiu-Ru Lin. (2008) ERCC22251A>C genetic polymorphism was highly correlated with early relapse in high-risk stage II and stage III colorectal cancer patients: A preliminary study. BMC Cancer 8:1.
Crossref
Crossref
Christina Peklak-Scott, Pamela K. Smitherman, Alan J. Townsend & Charles S. Morrow. (2008)
Role of glutathione
S
-transferase P1-1 in the cellular detoxification of cisplatin
. Molecular Cancer Therapeutics 7:10, pages 3247-3255.
Crossref
Crossref
Michela Pasello, Francesca Michelacci, Isabella Scionti, Claudia Maria Hattinger, Monia Zuntini, Anna Maria Caccuri, Katia Scotlandi, Piero Picci & Massimo Serra. (2008)
Overcoming Glutathione
S
-Transferase P1–Related Cisplatin Resistance in Osteosarcoma
. Cancer Research 68:16, pages 6661-6668.
Crossref
Crossref
Heleen M. Wortelboer, Michiel G.J. Balvers, Mustafa Usta, Peter J. van Bladeren & Nicole H.P. Cnubben. (2008) Glutathione-dependent interaction of heavy metal compounds with multidrug resistance proteins MRP1 and MRP2. Environmental Toxicology and Pharmacology 26:1, pages 102-108.
Crossref
Crossref
Ann M. Moyer, Oreste E. Salavaggione, Tse-Yu Wu, Irene Moon, Bruce W. Eckloff, Michelle A.T. Hildebrandt, Daniel J. Schaid, Eric D. Wieben & Richard M. Weinshilboum. (2008)
Glutathione
S
-Transferase P1: Gene Sequence Variation and Functional Genomic Studies
. Cancer Research 68:12, pages 4791-4801.
Crossref
Crossref
O’neil W. Guthrie, Ha-Sheng Li-Korotky, John D. Durrant & Carey Balaban. (2008) Cisplatin induces cytoplasmic to nuclear translocation of nucleotide excision repair factors among spiral ganglion neurons. Hearing Research 239:1-2, pages 79-91.
Crossref
Crossref
Enrica Eleuterio, Fabrizio Di Giuseppe, Marilisa Sulpizio, Viviana di Giacomo, Monica Rapino, Amelia Cataldi, Carmine Di Ilio & Stefania Angelucci. (2008) Proteome analysis of X-ray irradiated human erythroleukemia cells. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics 1784:4, pages 611-620.
Crossref
Crossref
Petra Heffeter, Ute Jungwirth, Michael Jakupec, Christian Hartinger, Mathea S. Galanski, Leonilla Elbling, Michael Micksche, Bernhard Keppler & Walter Berger. (2008) Resistance against novel anticancer metal compounds: Differences and similarities. Drug Resistance Updates 11:1-2, pages 1-16.
Crossref
Crossref
Richard Booton, Tim Ward, Linda Ashcroft, Julie Morris, Jim Heighway & Nick Thatcher. (2007) ERCC1 mRNA Expression Is Not Associated with Response and Survival after Platinum-Based Chemotherapy Regimens in Advanced Non-Small Cell Lung Cancer. Journal of Thoracic Oncology 2:10, pages 902-906.
Crossref
Crossref
Rui Wang, Chunmin Li, Dandan Song, Guisen Zhao, Linxiang Zhao & Yongkui Jing. (2007)
Ethacrynic Acid Butyl-Ester Induces Apoptosis in Leukemia Cells through a Hydrogen Peroxide–Mediated Pathway Independent of Glutathione
S
-Transferase P1-1 Inhibition
. Cancer Research 67:16, pages 7856-7864.
Crossref
Crossref
Hui-Wen Lo & Francis Ali-Osman. (2007) Genetic polymorphism and function of glutathione S-transferases in tumor drug resistance. Current Opinion in Pharmacology 7:4, pages 367-374.
Crossref
Crossref
Kenneth D. Tew. (2007) Redox in redux: Emergent roles for glutathione S-transferase P (GSTP) in regulation of cell signaling and S-glutathionylation. Biochemical Pharmacology 73:9, pages 1257-1269.
Crossref
Crossref
Annamaria RuzzoFrancesco GrazianoFotios LoupakisEliana RulliEmanuele CanestrariDaniele SantiniVincenzo CatalanoRita FicarelliPaolo MalteseRenato BisonniGianluca MasiGaia SchiavonPaolo GiordaniLucio GiustiniAlfredo FalconeGiuseppe ToniniRosarita SilvaRodolfo MattioliIrene FlorianiMauro Magnani. (2007) Pharmacogenetic Profiling in Patients With Advanced Colorectal Cancer Treated With First-Line FOLFOX-4 Chemotherapy. Journal of Clinical Oncology 25:10, pages 1247-1254.
Crossref
Crossref
H.-C. Kwon, M.S. Roh, S.Y. Oh, S.-H. Kim, M.C. Kim, J.-S. Kim & H.-J. Kim. (2007) Prognostic value of expression of ERCC1, thymidylate synthase, and glutathione S-transferase P1 for 5-fluorouracil/oxaliplatin chemotherapy in advanced gastric cancer. Annals of Oncology 18:3, pages 504-509.
Crossref
Crossref
Christina M. Nagle, Georgia Chenevix-Trench, Amanda B. Spurdle & Penelope M. Webb. (2007) The role of glutathione-S-transferase polymorphisms in ovarian cancer survival. European Journal of Cancer 43:2, pages 283-290.
Crossref
Crossref
Jan Stoehlmacher. 2007. Targeted Therapies in Cancer. Targeted Therapies in Cancer
81
88
.
Richard Booten, Tim Ward, Jim Heighway, Linda Ashcroft, Julie Morris & Nicholas Thatcher. (2006) Glutathione-S-Transferase P1 Isoenzyme Polymorphisms, Platinum-Based Chemotherapy, and Non-small Cell Lung Cancer. Journal of Thoracic Oncology 1:7, pages 679-683.
Crossref
Crossref
J. Stoehlmacher. (2006) The impact of genomics and proteomics in the clinic: functional genetic polymorphisms and their value in response and toxicity prediction in solid tumours. Annals of Oncology 17, pages x263-x268.
Crossref
Crossref
Richard Booten, Tim Ward, Jim Heighway, Linda Ashcroft, Julie Morris & Nicholas Thatcher. (2006) Glutathione-S-Transferase P1 Isoenzyme Polymorphisms, Platinum-Based Chemotherapy, and Non-small Cell Lung Cancer. Journal of Thoracic Oncology 1:7, pages 679-683.
Crossref
Crossref
Xifeng Wu, Jian Gu, Tsung-Teh Wu, Stephen G. Swisher, Zhongxin Liao, Arlene M. Correa, Jun Liu, Carol J. Etzel, Christopher I. Amos, Maosheng Huang, Silvia S. Chiang, Luke Milas, Walter N. Hittelman & Jaffer A. Ajani. (2006) Genetic Variations in Radiation and Chemotherapy Drug Action Pathways Predict Clinical Outcomes in Esophageal Cancer. Journal of Clinical Oncology 24:23, pages 3789-3798.
Crossref
Crossref
S Holley, A Fryer, Carroll, P Hoban & R Strange. 2006. Toxicology of Glutathione Transferases. Toxicology of Glutathione Transferases
129
154
.
Annamaria RuzzoFrancesco GrazianoKazuyuki KawakamiGo WatanabeDaniele SantiniVincenzo CatalanoRenato BisonniEmanuele CanestrariRita FicarelliEttore Tito MenichettiDavide MariEnrica TestaRosarita SilvaBruno VincenziPaolo GiordaniStefano CascinuLucio GiustiniGiuseppe ToniniMauro Magnani. (2006) Pharmacogenetic Profiling and Clinical Outcome of Patients With Advanced Gastric Cancer Treated With Palliative Chemotherapy. Journal of Clinical Oncology 24:12, pages 1883-1891.
Crossref
Crossref
C C McIlwain, D M Townsend & K D Tew. (2006) Glutathione S-transferase polymorphisms: cancer incidence and therapy. Oncogene 25:11, pages 1639-1648.
Crossref
Crossref
A. Beeghly, D. Katsaros, H. Chen, S. Fracchioli, Y. Zhang, M. Massobrio, H. Risch, B. Jones & H. Yu. (2006) Glutathione S-transferase polymorphisms and ovarian cancer treatment and survival. Gynecologic Oncology 100:2, pages 330-337.
Crossref
Crossref
Charles Lu, Margaret R. Spitz, Hua Zhao, Qiong Dong, Mylene Truong, Joe Y. Chang, George R. Blumenschein, Waun K. Hong & Xifeng Wu. (2006) Association between glutathione S-transferase π polymorphisms and survival in patients with advanced nonsmall cell lung carcinoma. Cancer 106:2, pages 441-447.
Crossref
Crossref
E Goekkurt, S Hoehn, C Wolschke, C Wittmer, C Stueber, D K Hossfeld & J Stoehlmacher. (2005) Polymorphisms of glutathione S-transferases (GST) and thymidylate synthase (TS) – novel predictors for response and survival in gastric cancer patients. British Journal of Cancer 94:2, pages 281-286.
Crossref
Crossref
Zahid H. Siddik. 2006. Cancer Drug Resistance. Cancer Drug Resistance
283
307
.
D. Vallböhmer & H. J. Lenz. 2006. Praxis der Viszeralchirurgie. Praxis der Viszeralchirurgie
111
119
.
L. de Chaisemartin & M.-A. Loriot. (2005) Pharmacogénétique des médicaments anticancéreux. Pathologie Biologie 53:2, pages 116-124.
Crossref
Crossref
Wee Han Ang, Isam Khalaila, Claire S. Allardyce, Lucienne Juillerat-Jeanneret & Paul J. Dyson. (2005) Rational Design of Platinum(IV) Compounds to Overcome Glutathione-S-Transferase Mediated Drug Resistance. Journal of the American Chemical Society 127:5, pages 1382-1383.
Crossref
Crossref
Jan Stöhlmacher. (2005) Pharmacogenetics in Gastrointestinal Tumors. Oncology Research and Treatment 28:8-9, pages 435-440.
Crossref
Crossref
Kensaku Kamada, Shinji Goto, Tomohiro Okunaga, Yoshito Ihara, Kentaro Tsuji, Yoshichika Kawai, Koji Uchida, Toshihiko Osawa, Takayuki Matsuo, Izumi Nagata & Takahito Kondo. (2004) Nuclear glutathione S-transferase π prevents apoptosis by reducing the oxidative stress-induced formation of exocyclic dna products. Free Radical Biology and Medicine 37:11, pages 1875-1884.
Crossref
Crossref
J Stoehlmacher, D J Park, W Zhang, D Yang, S Groshen, S Zahedy & H-J Lenz. (2004) A multivariate analysis of genomic polymorphisms: prediction of clinical outcome to 5-FU/oxaliplatin combination chemotherapy in refractory colorectal cancer. British Journal of Cancer 91:2, pages 344-354.
Crossref
Crossref
Hiroaki Toshimitsu, Kiichiro Hashimoto, Akira Tangoku, Norio Iizuka, Kohtaro Yamamoto, Shigeto Kawauchi, Atsunori oga, Tomoko Furuya, Masaaki Oka & Kohsuke Sasaki. (2004) Molecular signature linked to acquired resistance to cisplatin in esophageal cancer cells. Cancer Letters 211:1, pages 69-78.
Crossref
Crossref
Jan Stoehlmacher, Syma Iqbal & Heinz-Josef Lenz. 2004. Handbook of Anticancer Pharmacokinetics and Pharmacodynamics. Handbook of Anticancer Pharmacokinetics and Pharmacodynamics
231
243
.
Linda E. Bröker, José A. Rodriguez & Giuseppe Giaccone. 2004. Principles of Molecular Oncology. Principles of Molecular Oncology
463
489
.
Jan Stoehlmacher, Eray Goekkurt & Heinz-Josef Lenz. (2003) Pharmacogenetic aspects in treatment of colorectal cancer – an update. Pharmacogenomics 4:6, pages 767-777.
Crossref
Crossref
Zahid H Siddik. (2003) Cisplatin: mode of cytotoxic action and molecular basis of resistance. Oncogene 22:47, pages 7265-7279.
Crossref
Crossref
Shu Aizawa, Keizou Ookawa, Toshihiro Kudo, Junpei Asano, Makoto Hayakari & Shigeki Tsuchida. (2003) Characterization of cell death induced by ethacrynic acid in a human colon cancer cell line DLD-1 and suppression by N-acetyl-l-cysteine. Cancer Science 94:10, pages 886-893.
Crossref
Crossref
Sandrine Daubeuf, Diane Balin, Pierre Leroy & Athanase Visvikis. (2003) Different mechanisms for γ-glutamyltransferase-dependent resistance to carboplatin and cisplatin. Biochemical Pharmacology 66:4, pages 595-604.
Crossref
Crossref
Fengxi Su, Xiaoqu Hu, Weijuan Jia, Chang Gong, Erwei Song & Peter Hamar. (2003) Glutathion s transferase π indicates chemotherapy resistance in breast cancer. Journal of Surgical Research 113:1, pages 102-108.
Crossref
Crossref
Danyelle M. Townsend, Kenneth D. Tew & Haim Tapiero. (2003) The importance of glutathione in human disease. Biomedicine & Pharmacotherapy 57:3-4, pages 145-155.
Crossref
Crossref
N Takami, H Sakamoto & T Yamamoto. (2003) Steroid and Xenobiotic Receptor (SXR) is a Key System for the Acquisition of Cisplatin Resistance in Endometrial Cancer Cells. Journal of International Medical Research 31:2, pages 59-68.
Crossref
Crossref
S. Laufs, E.C. Buss, W.J. Zeller & S. Fruehauf. (2003) Transfer of drug resistance genes in hematopoietic progenitors for chemoprotection: is it still an option?. Drug Resistance Updates 6:2, pages 57-69.
Crossref
Crossref
Jan Stoehlmacher & Heinz-Josef Lenz. (2003) Implications of Genetic Testing in the Management of Colorectal Cancer. American Journal of PharmacoGenomics 3:2, pages 73-88.
Crossref
Crossref
Danyelle M. Townsend, Mei Deng, Lei Zhang, Maia G. Lapus & Marie H. Hanigan. (2003) Metabolism of Cisplatin to a Nephrotoxin in Proximal Tubule Cells. Journal of the American Society of Nephrology 14:1, pages 1-10.
Crossref
Crossref
Hideki Sakamoto, Noriko Takami & Tatsuo Yamamoto. 2003. Cell and Molecular Biology of Endometrial Carcinoma. Cell and Molecular Biology of Endometrial Carcinoma
283
294
.
Tricia M. Ishimoto & Francis Ali-Osman. (2002) Allelic variants of the human glutathione S-transferase P1 gene confer differential cytoprotection against anticancer agents in Escherichia coli. Pharmacogenetics 12:7, pages 543-553.
Crossref
Crossref
Jing Wen, Kyung-Ran You, So-Youn Lee, Chang-Ho Song & Dae-Ghon Kim. (2002) Oxidative Stress-mediated Apoptosis. Journal of Biological Chemistry 277:41, pages 38954-38964.
Crossref
Crossref
Shinji Goto, Kensaku Kamada, Yoko Soh, Yoshito Ihara & Takahito Kondo. (2005) Significance of Nuclear Glutathione S‐Transferase π in Resistance to Anti‐cancer Drugs. Japanese Journal of Cancer Research 93:9, pages 1047-1056.
Crossref
Crossref
Masaharu Tani, Shinji Goto, Kensaku Kamada, Katsuharu Mori, Yoshishige Urata, Yoshito Ihara, Hiroshi Kijima, Yoshito Ueyama, Shobu Shibata & Takahito Kondo. (2005) Hammerhead Ribozyme against γ‐Glutamylcysteine Synthetase Attenuates Resistance to Ionizing Radiation and Cisplatin in Human T98G Glioblastoma Cells. Japanese Journal of Cancer Research 93:6, pages 716-722.
Crossref
Crossref
David Hamilton, Nasser Fotouhi-Ardakani & Gerald Batist. 2002. Clinically Relevant Resistance in Cancer Chemotherapy. Clinically Relevant Resistance in Cancer Chemotherapy
67
87
.
Zahid H. Siddik. 2002. Clinically Relevant Resistance in Cancer Chemotherapy. Clinically Relevant Resistance in Cancer Chemotherapy
263
284
.
Hui‐Wen Lo & Francis Ali‐Osman. (2002) Cyclic AMP mediated GSTP1 gene activation in tumor cells involves the interaction of activated CREB‐1 with the GSTP1 CRE: A novel mechanism of cellular GSTP1 gene regulation. Journal of Cellular Biochemistry 87:1, pages 103-116.
Crossref
Crossref
Shinji Goto, Yoshito Ihara, Yoshishige Urata, Shinichi Izumi, Kuniko Abe, Takehiko Koji & Takahito Kondo. (2001)
Doxorubicin‐induced DNA intercalation and scavenging by nuclear glutathione
S
‐transferase π
. The FASEB Journal 15:14, pages 2702-2714.
Crossref
Crossref
Mark A. Morse. (2001) The role of glutathione S-transferase P1-1 in colorectal cancer: Friend or foe?. Gastroenterology 121:4, pages 1010-1013.
Crossref
Crossref
Tetsuya Iida, Hiroshi Kijima, Yoshishige Urata, Shinji Goto, Yoshito Ihara, Mikio Oka, Shigeru Kohno, Kevin J Scanlon & Takahito Kondo. (2001) Hammerhead ribozyme against γ-glutamylcysteine synthetase sensitizes human colonic cancer cells to cisplatin by down-regulating both the glutathione synthesis and the expression of multidrug resistance proteins. Cancer Gene Therapy 8:10, pages 803-814.
Crossref
Crossref
Junko Nagata, Hiroshi Kijima, Hiroyuki Hatanaka, Satomi Asai, Hayato Miyachi, Atsushi Takagi, Takeshi Miwa, Tetsuya Mine, Hitoshi Yamazaki, Masato Nakamura, Takahito Kondo, Kevin J. Scanlon & Yoshito Ueyama. (2001) Reversal of Cisplatin and Multidrug Resistance by Ribozyme-Mediated Glutathione Suppression. Biochemical and Biophysical Research Communications 286:2, pages 406-413.
Crossref
Crossref